Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2012

01.02.2012 | Original Article

Prevalence and Distribution of Adenomas in Black Americans Undergoing Colorectal Cancer Screening

verfasst von: Frank K. Friedenberg, Mandeep Singh, Nina S. George, Abhinav Sankineni, Swetang Shah

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

The American College of Gastroenterology recommends colorectal cancer (CRC) screening for average-risk black Americans ages 45–49. This is based on this group’s younger age for the development of adenomas and CRC. Our purpose was to determine the yield of CRC screening in average-risk black Americans including those <age 50. We also aimed to identify whether there was a higher prevalence of proximal adenomas in black Americans.

Study

This was a cross-sectional, retrospective study. All colonoscopy examinations from 2007 through 2010 were reviewed. Complete examinations with a good/excellent preparation in average-risk black patients 45–49 were selected. We excluded patients with signs, symptoms, or family history of CRC. Defined two control groups: average-risk black and white patients ages 50–59 who completed a colonoscopy during the same period. Patient’s height, weight, and use of statin medications and aspirin were recorded. Patients currently using tobacco at least weekly were identified.

Results

There were 1,230 patients with an adenoma for a prevalence of 40.7%. We included 304 black Americans 45–49 years, 669 black Americans 50–59 years, and 257 whites 50–59 years. There was no association between race/age group and the presence of at least one adenoma, proximal adenomas, or advanced adenomas. In regression modeling, both male sex and active smoking were associated with all three outcomes.

Conclusions

Male sex and active smoking are risk factors for prevalent adenomas, proximal adenomas, and advanced adenomas. The prevalence of adenomas is similar in black Americans 45–49 compared to older black and white patients. We did not find that the recognized proximal distribution of CRC in black Americans parallels a similar distribution in adenomas in this group.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRef Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.PubMedCrossRef
3.
Zurück zum Zitat Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104:629–639.PubMedCrossRef Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005;104:629–639.PubMedCrossRef
4.
Zurück zum Zitat Cheng X, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer. 2001;92:2547–2554.PubMedCrossRef Cheng X, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992–1997. Cancer. 2001;92:2547–2554.PubMedCrossRef
5.
Zurück zum Zitat Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312–2320.PubMedCrossRef Dominitz JA, Samsa GP, Landsman P, Provenzale D. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system. Cancer. 1998;82:2312–2320.PubMedCrossRef
6.
Zurück zum Zitat Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137:550–554.PubMedCrossRef Wudel LJ, Chapman WC, Shyr Y, et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. Arch Surg. 2002;137:550–554.PubMedCrossRef
7.
Zurück zum Zitat Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686–1693.PubMedCrossRef Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87:1686–1693.PubMedCrossRef
8.
Zurück zum Zitat Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:1087–1093.PubMed Chen VW, Fenoglio-Preiser CM, Wu XC, et al. Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:1087–1093.PubMed
9.
Zurück zum Zitat Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The national cancer data base. Report on colon cancer. Cancer. 1996;78:918–926.PubMedCrossRef Jessup JM, McGinnis LS, Steele GD Jr, Menck HR, Winchester DP. The national cancer data base. Report on colon cancer. Cancer. 1996;78:918–926.PubMedCrossRef
10.
Zurück zum Zitat Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–2270.PubMedCrossRef Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–2270.PubMedCrossRef
11.
Zurück zum Zitat O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371–379.PubMed O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990;98:371–379.PubMed
12.
Zurück zum Zitat Fenoglio CM, Pascal RR. Colorectal adenomas and cancer: pathologic relationships. Cancer. 1982;50:2601–2608.PubMed Fenoglio CM, Pascal RR. Colorectal adenomas and cancer: pathologic relationships. Cancer. 1982;50:2601–2608.PubMed
13.
Zurück zum Zitat Granqvist S. Distribution of polyps in the large bowel in relation to age. A colonoscopic study. Scand J Gastroenterol. 1981;16:1025–1031.PubMedCrossRef Granqvist S. Distribution of polyps in the large bowel in relation to age. A colonoscopic study. Scand J Gastroenterol. 1981;16:1025–1031.PubMedCrossRef
14.
Zurück zum Zitat Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532.PubMedCrossRef Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532.PubMedCrossRef
15.
Zurück zum Zitat Chu DZ, Giacco G, Martin RG, Guinee VF. The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer. 1986;57:445–450.PubMedCrossRef Chu DZ, Giacco G, Martin RG, Guinee VF. The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer. 1986;57:445–450.PubMedCrossRef
16.
Zurück zum Zitat Johnson H Jr, Carstens R. Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer. 1986;58:997–1000.PubMedCrossRef Johnson H Jr, Carstens R. Anatomical distribution of colonic carcinomas. Interracial differences in a community hospital population. Cancer. 1986;58:997–1000.PubMedCrossRef
17.
Zurück zum Zitat Offerhaus GJ, Giardiello FM, Tersmette KW, et al. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer. 1991;49:641–644.PubMedCrossRef Offerhaus GJ, Giardiello FM, Tersmette KW, et al. Ethnic differences in the anatomical location of colorectal adenomatous polyps. Int J Cancer. 1991;49:641–644.PubMedCrossRef
18.
Zurück zum Zitat Rex DK, Khan AM, Shah P, Newton J, Cummings OW. Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc. 2000;51:524–527.PubMedCrossRef Rex DK, Khan AM, Shah P, Newton J, Cummings OW. Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc. 2000;51:524–527.PubMedCrossRef
19.
Zurück zum Zitat Dominic OG, McGarrity T, Dignan M, Lengerich EJ. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:2626–2627.PubMedCrossRef Dominic OG, McGarrity T, Dignan M, Lengerich EJ. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:2626–2627.PubMedCrossRef
20.
Zurück zum Zitat Robertson DJ, Burke CA, Welch HG, et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009;151:103–109.PubMed Robertson DJ, Burke CA, Welch HG, et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med. 2009;151:103–109.PubMed
21.
Zurück zum Zitat Ozick LA, Jacob L, Donelson SS, Agarwal SK, Freeman HP. Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol. 1995;90:758–760.PubMed Ozick LA, Jacob L, Donelson SS, Agarwal SK, Freeman HP. Distribution of adenomatous polyps in African-Americans. Am J Gastroenterol. 1995;90:758–760.PubMed
22.
Zurück zum Zitat Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.PubMedCrossRef Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA. 2008;300:1417–1422.PubMedCrossRef
23.
Zurück zum Zitat Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007;99:723–728.PubMed Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM. Racial variation in colorectal polyp and tumor location. J Natl Med Assoc. 2007;99:723–728.PubMed
24.
Zurück zum Zitat Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.PubMed Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.PubMed
25.
Zurück zum Zitat Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–523.PubMedCrossRef Agrawal S, Bhupinderjit A, Bhutani MS, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515–523.PubMedCrossRef
26.
Zurück zum Zitat Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.PubMed Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.PubMed
27.
Zurück zum Zitat Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99–119.PubMedCrossRef Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60:99–119.PubMedCrossRef
28.
Zurück zum Zitat Penn E, Garrow D, Romagnuolo J. Influence of race and sex on prevalence and recurrence of colon polyps. Arch Intern Med. 2010;170:1127–1132.PubMedCrossRef Penn E, Garrow D, Romagnuolo J. Influence of race and sex on prevalence and recurrence of colon polyps. Arch Intern Med. 2010;170:1127–1132.PubMedCrossRef
29.
Zurück zum Zitat Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 2006;15:897–901.PubMedCrossRef Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 2006;15:897–901.PubMedCrossRef
30.
Zurück zum Zitat Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol. 2009;7:682–688.e1-5. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol. 2009;7:682–688.e1-5.
31.
Zurück zum Zitat Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134:388–395.PubMedCrossRef Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134:388–395.PubMedCrossRef
32.
Zurück zum Zitat Zhao J, Halfyard B, Roebothan B, et al. Tobacco smoking and colorectal cancer: a population-based case-control study in Newfoundland and Labrador. Can J Public Health. 2010;101:281–289.PubMed Zhao J, Halfyard B, Roebothan B, et al. Tobacco smoking and colorectal cancer: a population-based case-control study in Newfoundland and Labrador. Can J Public Health. 2010;101:281–289.PubMed
33.
Zurück zum Zitat Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab. 2004;5:363–373.PubMedCrossRef Nishikawa A, Mori Y, Lee IS, Tanaka T, Hirose M. Cigarette smoking, metabolic activation and carcinogenesis. Curr Drug Metab. 2004;5:363–373.PubMedCrossRef
34.
Zurück zum Zitat Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121:241–246.PubMed Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121:241–246.PubMed
35.
Zurück zum Zitat Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891–899.PubMedCrossRef Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891–899.PubMedCrossRef
36.
Zurück zum Zitat Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–266.PubMedCrossRef Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94:252–266.PubMedCrossRef
37.
Zurück zum Zitat Herendeen JM, Lindley C. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother. 2003;37:1664–1674.PubMedCrossRef Herendeen JM, Lindley C. Use of NSAIDs for the chemoprevention of colorectal cancer. Ann Pharmacother. 2003;37:1664–1674.PubMedCrossRef
38.
Zurück zum Zitat Iishi H, Tatsuta M, Baba M, et al. ras p21 Isoprenylation inhibition induces flat colon tumors in Wistar rats. Dis Colon Rectum. 2000;43:70–75.PubMedCrossRef Iishi H, Tatsuta M, Baba M, et al. ras p21 Isoprenylation inhibition induces flat colon tumors in Wistar rats. Dis Colon Rectum. 2000;43:70–75.PubMedCrossRef
39.
Zurück zum Zitat Siddiqui A, Nazario HE, Patel M, Mahgoub A, Spechler SJ. Reduction in low-density lipoprotein cholesterol levels during statin therapy is associated with a reduced incidence of advanced colon polyps. Am J Med Sci. 2009;338:378–381.PubMedCrossRef Siddiqui A, Nazario HE, Patel M, Mahgoub A, Spechler SJ. Reduction in low-density lipoprotein cholesterol levels during statin therapy is associated with a reduced incidence of advanced colon polyps. Am J Med Sci. 2009;338:378–381.PubMedCrossRef
Metadaten
Titel
Prevalence and Distribution of Adenomas in Black Americans Undergoing Colorectal Cancer Screening
verfasst von
Frank K. Friedenberg
Mandeep Singh
Nina S. George
Abhinav Sankineni
Swetang Shah
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1952-z

Weitere Artikel der Ausgabe 2/2012

Digestive Diseases and Sciences 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.